Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by ledrogon May 07, 2019 6:08pm
195 Views
Post# 29722035

RE:RE:RE:RE:RE:RE:RE:RE:COMPETATION TO RVX208??

RE:RE:RE:RE:RE:RE:RE:RE:COMPETATION TO RVX208??I think it was rvxoldtimer over on Agora who brought up Fibs....or fibonaci resistance points, and mentioned $7.50 (or so) as the next point of resistance assuming the PPS broke above $4.50....I myself don't know much about Fibs.....until reading The Davinci Code I didn't even understand them, now I have a very basic understanding but I don't know how they're used to calculate projected support and resistance areas....but I know there are lots of people who do use them.

In general less technical terms...I like the chances for the PPS to keep moving based on the still incredibly thin volumes we're seeing.  As a point of reference, for me a BIG volume day would be one with 5 to 10% of the outstanding share count trading....10 to 20 million in other words.  A decent day's trading in my books would be 1% or so....or 2 million.  

Add up all the Canadian trading today and we get almost 180,000, OTC rvxcf only traded about 40K....so today for me equalled about 10% of what I'd consider a decent volume day.  I think the reason volumes are so low is that there simply aren't enough sellers....and if buyers stormed in and bought 2 million shares in a day.....imo that would absolutely skyrocket the PPS, perhaps right past $7.50 all the way to $10+......and so we trade light and climb slow and steady.....

If we did get a day with 2 or 3 million trading and a huge jump in the PPS......then a sharp correction would probably follow.  
Bullboard Posts